Publication | Closed Access

Metabolomics and integrated network pharmacology analysis reveal Tricin as the active anti-cancer component of Weijing decoction by suppression of PRKCA and sphingolipid signaling

Chemoprevention StrategyBiochemistryMedicineSphingolipid SignalingMetabolomic ProfilingAnti-cancer AgentMetabolic ProfilingMetabolomicsSystems BiologyPharmacologyActive Anti-cancer ComponentDrug Discovery